Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.22B
Enterprise Value4.91B
P/E Ratio49.89
PEG Ratio-5.19
Price/Sales Ratio6.55
Price/Book Ratio1.1
Enterprise/Revenue6.21
Enterprise/EBITDA31.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.13
Operating Margin0.13
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue649.51M
Revenue/Share3.62
Gross Profit104.69M
EBITDA103.66M
Net Income91.41M
Diluted EPS0.46

Balance Sheet

Total Cash1.13B
Total Cash/Share5.66
Total Debt13.16M
Total Debt/Equity0
Current Ratio10.56
Book Value Per Share21.33

Price History

52-Week Change-20.86
52-Week High31.33
52-Week Low21.81
Moving Average 50 Days23.7
Moving Average 200 Days26.28

Statistics

Average Volume1.32M
Shares Outstanding202.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield4.26
Payout Ratio1.07
Last Split Factor3:2
Last Split DateJune 17, 2022
AD